Orion's OB-002 shown to be more potent than maraviroc in a model of HIV infection July 25, 2019 No Comments
Merck & Co. presents clinical data for MK-8591 in patients with HIV-1 infection July 25, 2019 No Comments
Dolutegravir recommended by WHO for first-line and second-line treatment for HIV July 23, 2019 No Comments
RSS